- Malaysia
- /
- Personal Products
- /
- KLSE:BIOHLDG
Bioalpha Holdings Berhad Second Quarter 2024 Earnings: RM0.005 loss per share (vs RM0.003 loss in 2Q 2023)
Bioalpha Holdings Berhad (KLSE:BIOHLDG) Second Quarter 2024 Results
Key Financial Results
- Revenue: RM23.0m (up 170% from 2Q 2023).
- Net loss: RM7.41m (loss widened by 120% from 2Q 2023).
- RM0.005 loss per share (further deteriorated from RM0.003 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Bioalpha Holdings Berhad's share price is broadly unchanged from a week ago.
Risk Analysis
Before you take the next step you should know about the 3 warning signs for Bioalpha Holdings Berhad (1 is potentially serious!) that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if Bioalpha Holdings Berhad might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KLSE:BIOHLDG
Bioalpha Holdings Berhad
An investment holding company, researches, develops, manufactures, imports, exports, trades in, and distributes nutritional and healthcare products in Malaysia, China, Indonesia, and internationally.
Excellent balance sheet low.